Thomas Snyder is a New York, New York based neurologist who is specialized in Neurology. Active license number of Thomas Snyder is 25MA11410600 for Neurology in New Jersey. His current practice location is 550 1st Ave, New York. Patients can reach him at 212-263-5506. Thomas Snyder NPI number (Unique professional ID assigned by NPPES) is 1467949909. Thomas Snyder specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Thomas Snyder speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Thomas Snyder
Specialization:
Neurology
Gender:
Male
Practice Address:
550 1st Ave, New York, New York, 10016
Phone:
212-263-5506
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1467949909
NPI Enumeration Date:
19 Apr, 2018
NPI Last Update On:
29 Sep, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Thomas Snyder are as mentioned below.
License Number
Specialization
State
Status
25MA11410600
Neurology
New Jersey
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Thomas Snyder 99 New St Apt 410, Metuchen, New Jersey
Zip:
08840-1977
Phone Number:
917-670-4995
Patients can reach Thomas Snyder at 550 1st Ave, New York, New York or can call to book an appointment on 212-263-5506.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.